Interactive Session:
75. Clinical Controversies
Thursday, October 4, 2018: 2:00 PM-3:15 PM
Room: W 2005-2024

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • contrast the advantages and disadvantages of prescribing probiotics for all hospitalized patients who are taking antibiotics
  • critically analyze available data suggesting that HIV persons with an undetectable viral load are not infectious to others
  • define the risks and benefits of maintaining IV access after hospital discharge in persons known to use illicit IV drugs

Target Audience: Academicians, Clinicians, Fellows, HIV clinicians, HIV specialists, Infectious diseases physicians, Medical students and residents, Members-in-training, Pharmacists

Tracks: Epidemiology and Infection Control, Pediatric ID, Trainee, Adult ID


Interactive Moderators:  Patrick Joseph, MD, FIDSA, FSHEA, University of California, San Francisco and Ann MacIntyre, DO, MHS, Mercy Hospital

Presentations:
2:00 PM
Probiotics for ALL in-patients on antibiotics?
 
818
PRO
Trish Perl, MD, MSc, FIDSA, FSHEA

 
819
CON
Neil O. Fishman, MD, FSHEA

2:25 PM
“U=U” ? Does HIV Undetectable mean Untransmittable?
 
820
PRO
Lisa G. Winston, MD

 
821
CON
Roy M. Gulick, MD, MPH, FIDSA

2:50 PM
PICC lines for IVDU at Discharge. Acceptable or Not?
 
822
PRO
Shireesha Dhanireddy, MD

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™

ACPE Credits: ACPE 1.25 knowledge-based contact hours of pharmacy CE

ACPE Number: 0221-9999-18-309-L01-P

Disclosures:

P. Joseph, None

A. MacIntyre, None

See more of: Interactive Session

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.